Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$26.7 - $37.02 $647,154 - $897,290
-24,238 Reduced 7.58%
295,544 $10.4 Million
Q1 2023

May 15, 2023

SELL
$26.64 - $39.74 $5.27 Million - $7.86 Million
-197,744 Reduced 38.21%
319,782 $9.08 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $4.95 Million - $8.11 Million
160,034 Added 44.77%
517,526 $21.5 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $10.4 Million - $15.9 Million
357,492 New
357,492 $11.7 Million
Q1 2022

May 16, 2022

SELL
$16.89 - $35.74 $1.1 Million - $2.32 Million
-65,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $2.33 Million - $2.73 Million
65,000 New
65,000 $2.48 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.